Since one of the major objectives of therapeutic treatments is to overcome the resistance of cancer to cell death [36, 37], we investigated whether IFN-α was capable to potentiate any pro-apoptotic effect eventually exerted by the epigenetic drugs. Here, IFNA1 is linked to cancer.